Significance of a Positive Crossmatch on Outcome in Human Liver Transplantation
Overview
Affiliations
What's new in clinical solid organ transplantation by 2013.
Salvadori M, Bertoni E World J Transplant. 2014; 4(4):243-66.
PMID: 25540734 PMC: 4274595. DOI: 10.5500/wjt.v4.i4.243.
Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
OLeary J, Kaneku H, Demetris A, Marr J, Shiller S, Susskind B Liver Transpl. 2014; 20(2):218-27.
PMID: 24382837 PMC: 4623588. DOI: 10.1002/lt.23788.
Kaneku H, OLeary J, Banuelos N, Jennings L, Susskind B, Klintmalm G Am J Transplant. 2013; 13(6):1541-8.
PMID: 23721554 PMC: 4408873. DOI: 10.1002/ajt.12212.
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
OLeary J, Gebel H, Ruiz R, Bray R, Marr J, Zhou X Am J Transplant. 2013; 13(4):954-960.
PMID: 23433356 PMC: 4412610. DOI: 10.1111/ajt.12147.
OLeary J, Kaneku H, Susskind B, Jennings L, Neri M, Davis G Am J Transplant. 2011; 11(9):1868-76.
PMID: 21672151 PMC: 4412604. DOI: 10.1111/j.1600-6143.2011.03593.x.